Narihata, K., Sakoda, Y., Minamiguchi, M., Hata, M. Development and evaluation of electrostatic aerosol-to-hydrosol sampler for single-pass airborne influenza virus sampling. Aerosol Science and Technology, 1–14
Effective control measures are needed to combat airborne (aerosol) viruses present in human respiratory droplets. To assess virus inactivation, an aerosol sampler capable of collecting viruses while preserving their infectivity is required. This study developed a rotating electrostatic aerosol-to-hydrosol sampler (REAHS) with a low pressure drop and concentrated sampling. To minimize the loss of infectious viruses due to ozone generated during electrostatic collection, a new electrode was designed to suppress ozone production while maintaining collection efficiency. The electrode has a two-step central diameter, reducing the corona discharge area while ensuring the high electric field strength required for collection. Tests using simulated viral particles confirmed a collection efficiency greater than 80% for submicron particles (25–660?nm) while maintaining the ozone concentration at 0.076 parts per million. In addition, experiments with infectious influenza viruses demonstrated that the system collected viruses at concentrations 13.3 times higher than those of a gelatin filter while preserving infectivity. These findings suggest that the REAHS is a suitable sampler for additional studies on the efficacy of airborne virus inactivation.
See Also:
Latest articles in those days:
- Characterisation of a human monoclonal antibody targeting a conserved epitope at the base of the HA head of influenza A(H3N2) virus 6 hours ago
- An outbreak report of Influenza A(H3) among residents of a large nursing home in northern Italy: attack rates, clinical features and outcomes 19 hours ago
- Susceptibility of calves fed unpasteurized milk from cows infected with highly pathogenic avian influenza H5N1 20 hours ago
- Functional mapping of IFITM3 resolves its antiviral core and deciphers human influenza susceptibility 20 hours ago
- Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection 20 hours ago
[Go Top] [Close Window]


